Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancer.

Philip W. Kantoff; Marc B. Garnick

doi:10.1200/jco.1988.6.8.1216

August 1, 1988Journal of Clinical Oncology

Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancer.

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Article Tools Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.1988.6.8.1216 Journal of Clinical Oncology - published online before print September 22, 2016 PMID: 2842462 Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancer. P W KantoffxP W KantoffSearch for articles by this author , M B GarnickxM B GarnickSearch for articles by this author Show More Dana-Farber Cancer Institute, Harvard Medical School, Boston. https://doi.org/10.1200/JCO.1988.6.8.1216 First Page PDF © 1988 by American Society of Clinical Oncology

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kantoff et al. (1988) studied this question.

synapsesocial.com/papers/6a7d4546a88f8d6a78a0098b https://doi.org/10.1200/jco.1988.6.8.1216

View at Publisher

Ask AI

Bookmark

Share

Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancer.

Ask about this paper

Abstract

Discussion

Cite This Study

Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancer.

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading